Bundamedik Tbk PT (BMHS) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.083x

Based on the latest financial reports, Bundamedik Tbk PT (BMHS) has a cash flow conversion efficiency ratio of 0.083x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp199.64 Billion ≈ $11.70 Million USD) by net assets (Rp2.39 Trillion ≈ $140.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Bundamedik Tbk PT fund operations to measure how many days the company can operate on defensive assets alone.

Bundamedik Tbk PT - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Bundamedik Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bundamedik Tbk PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bundamedik Tbk PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sao Mai Group Corp
VN:ASM
-0.024x
q.beyond AG
F:QBY
0.035x
Finder Energy Holdings Ltd
AU:FDR
-0.630x
Ryvu Therapeutics SA
WAR:RVU
-0.553x
RF Acquisition Corp II Ordinary Shares
NASDAQ:RFAI
-0.006x
TMT Steel Public Company Limited
BK:TMT
0.160x
Vaziva Sa
PA:ALVAZ
N/A
Max India Limited
NSE:MAXIND
-0.098x

Annual Cash Flow Conversion Efficiency for Bundamedik Tbk PT (2018–2025)

The table below shows the annual cash flow conversion efficiency of Bundamedik Tbk PT from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see BMHS stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rp2.39 Trillion
≈ $140.31 Million
Rp250.62 Billion
≈ $14.69 Million
0.105x +561.56%
2024-12-31 Rp2.15 Trillion
≈ $125.85 Million
Rp33.98 Billion
≈ $1.99 Million
0.016x -44.64%
2023-12-31 Rp1.80 Trillion
≈ $105.47 Million
Rp51.44 Billion
≈ $3.01 Million
0.029x -78.24%
2022-12-31 Rp1.81 Trillion
≈ $105.96 Million
Rp237.47 Billion
≈ $13.91 Million
0.131x -36.61%
2021-12-31 Rp1.69 Trillion
≈ $98.84 Million
Rp349.44 Billion
≈ $20.48 Million
0.207x +14.24%
2020-12-31 Rp1.05 Trillion
≈ $61.51 Million
Rp190.36 Billion
≈ $11.15 Million
0.181x +34.54%
2019-12-31 Rp665.59 Billion
≈ $39.00 Million
Rp89.72 Billion
≈ $5.26 Million
0.135x +63.82%
2018-12-31 Rp532.23 Billion
≈ $31.19 Million
Rp43.79 Billion
≈ $2.57 Million
0.082x --

About Bundamedik Tbk PT

JK:BMHS Indonesia Medical Care Facilities
Market Cap
$91.25 Million
Rp1.56 Trillion IDR
Market Cap Rank
#19644 Global
#336 in Indonesia
Share Price
Rp181.00
Change (1 day)
+0.56%
52-Week Range
Rp147.00 - Rp226.00
All Time High
Rp1133.21
About

PT Bundamedik Tbk provides health care services in Indonesia. It also engages private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, and dental clinic services management consulting businesses. It also provides ferti… Read more